Define Value in Pharma Dev Value Stream mapping
Six Sigma – iSixSigma › Forums › Old Forums › Healthcare › Define Value in Pharma Dev Value Stream mapping
- This topic has 0 replies, 1 voice, and was last updated 13 years, 1 month ago by
Michael Herskovitz.
Viewing 1 post (of 1 total)
-
AuthorPosts
-
May 28, 2009 at 7:24 pm #25772
Michael HerskovitzParticipant@Michael-HerskovitzInclude @Michael-Herskovitz in your post and this person will
be notified via email.A critical phase of pharmaceutical development is the set of integrated activities that begin at the end of DP 3, proceed through scale-up of API and the making of pre-clinical and clinical supplies, and ending with the NDA filing in DP 7.
I am interested in starting a dialog around what Values should one consider in deciding how best to value-stream-map this phase of Pharma Dev.0 -
AuthorPosts
Viewing 1 post (of 1 total)
The forum ‘Healthcare’ is closed to new topics and replies.